Michelson Diagnostics Ltd

Michelson Diagnostics Ltd is the world leader in practical Optical Coherence Tomography (OCT) dermatology applications. Founded in 2006 by five physicists and engineers, the company develops and manufactures VivoSight Dx Pro, a state-of-the-art OCT skin imaging system used in clinical dermatology, commercial research, and academic skin research. VivoSight employs eye-safe infrared scanning laser light to provide non-invasive, high-resolution (sub-10 μm) 3D morphologic and angiographic imaging of skin microstructure up to 1 mm depth with a 6 mm × 6 mm field-of-view. The system enables objective measurement of skin parameters for diagnosis and monitoring of conditions including basal cell carcinoma, eczema, atopic dermatitis, and vascular lesions (port wine stain). The VivoSight product line has been cited in over 800 peer-reviewed publications. The company holds EU MDR certification and operates globally from offices in the UK, USA, and Germany, serving dermatology practices, hospitals, and research institutions.